Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms MAGNA VICTORIA
- 22 Dec 2017 Planned End Date changed from 1 Mar 2016 to 1 Sep 2018.
- 22 Dec 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Sep 2018.
- 22 Dec 2017 Status changed from completed to active, no longer recruiting.